Breast milk sampling

PROCEDURE3 trials

Sponsors

UCB BIOSCIENCES, Inc., AbbVie, ANRS, Emerging Infectious Diseases

Conditions

Ankylosing SpondylitisArbovirus InfectionsAxial Spondyloarthritis (AxSpA)Crohn's DiseaseHBV InfectionHCV InfectionHDV InfectionHIV Infection

Phase 1

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers

CompletedNCT02154425

UCB BIOSCIENCES, Inc.Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Crohn's Disease +3

Start: 2014-09-30End: 2016-01-31Updated: 2018-04-03

Phase 4

A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease

CompletedNCT06346288

AbbVieInflammatory Bowel Disease

Start: 2024-04-24End: 2026-02-05Updated: 2026-02-27

Unknown Phase

"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"

Not yet recruitingNCT07412977

ANRS, Emerging Infectious DiseasesArbovirus Infections, HBV Infection, HCV Infection +2

Start: 2026-02-01End: 2039-12-01Target: 5160Updated: 2026-02-17

Related Papers

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease.

2021-02-056 citations

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.

2017-08-16101 citations

Evaluating Transfer of Certolizumab Pegol and Polyethylene Glycol into Breast Milk [28J]

Obstetrics and Gynecology2017-05-01

Evaluating Transfer of Certolizumab Pegol into Breast Milk: Results from CRADLE, a Prospective, Postmarketing, Multicenter Pharmacokinetics Study

The American Journal of Gastroenterology2016-10-01